The Bone Growth Stimulators Market size in Europe was worth USD 0.31 Billion in 2021 and is estimated to be growing at a CAGR of 5.44% to reach USD 0.40 Billion by 2026 during the forecast period.
Patients' increasing preference for non-invasive and minimally invasive surgical treatments, the rising prevalence of target disorders, and the rising number of sports and accident-related orthopedic injuries drive the European bone growth stimulators market forward. In addition, the bone growth stimulators market is also being driven by factors such as an increase in the geriatric population, an increase in the incidence of fractures and accidents, a rise in diabetes, and other medical issues such as obesity, vascular disease, and kidney damage; an increase in the prevalence of arthritis, an increase in platelet-rich plasma and bone morphogenetic proteins, and the availability of low-cost bone growth stimulation devices.
Increased patient awareness of bone growth stimulators, procedural benefits of bone growth stimulation devices in the treatment of bone fractures and orthopedic diseases, technological advancements in bone growth stimulators, and an increase in the adoption rate of bone growth stimulators by both patients and prescribers all contribute to the growth of the bone growth stimulators market. Bone Development Stimulators are devices that aid in promoting bone growth in situations where fracture healing is problematic. To stimulate healing, these devices use the technique of administering electric current. In addition to spinal fusion, bone growth stimulators are employed as a supplement. The key elements driving this trend include rising occurrences of arthritis and osteoporosis and technological innovation. Furthermore, owing to the significant cost reductions, many patients from this country are known to fly to these rising markets for medical care.
Limited medical reimbursement for bone stimulation devices, high treatment costs associated with BMP and PRP products, and adverse effects connected with BMP-based orthopedic treatment are the key factors restricting the growth of the bone growth stimulator market. In addition, the market's growth is projected to be hampered by a strict approval process and limited medical rules for bone stimulation products.
This research report on the European bone growth stimulators market has been segmented and sub-segmented into the following categories.
By Product:
By Application:
By End User:
By Country:
Due to the significant need for innovative therapies for chronic conditions and the local presence of renowned medical device manufacturers such as Medtronic, Orthofix Holdings, Inc, Zimmer Biomet, and Bioventus, the second-largest market for bone growth stimulators was Europe in 2020. The regional mark is likely driven by highly developed healthcare infrastructure, mainly in Germany, Switzerland, the United Kingdom, and France. During the pandemic, there was a significant increase in hip fractures, particularly among the elderly in the United Kingdom, attributed in part to a lack of caretakers and families to look after the elderly. As a result, the rising number of fractures and trauma cases among the senior population during the pandemic puts the attention on bone growth stimulators, which drives up the price of these drugs. Despite an increase in minor injuries requiring minor surgery during the COVID-19 era, the number of polytrauma and open fractures decreased due to reduced road traffic and increased involvement in outdoor activities. The increased incidence of bone fracture cases and the efficiency of external bone growth stimulators in mending fractures drive up demand for these devices. Fragility fractures accounted for 2.9 million in the European Union's major five countries plus Sweden in 2019, according to a study published in the Archives of Osteoporosis, 2020. Furthermore, the increased focus of top manufacturers on expanding their geographic presence in rising countries to acquire a large share of the bone growth stimulators market is likely to fuel the region's expansion.
KEY MARKET PLAYERS:
A few prominent companies operating in the European bone growth stimulators market are DJO LLC, Orthofix International N.V., Zimmer Biomet Holdings Inc., Elizur, Bioventus LLC., Ossatec Benelux BV, Verve Consulting Inc., and IGEA S.p.A.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Bone Growth Stimulation Devices
5.1.2.1 External Bone Growth Stimulators
5.1.2.2 Implanted Bone Growth Stimulators
5.1.2.3 Ultrasonic Bone Growth Stimulators
5.1.3 Bone Morphogenetic Proteins
5.1.4 Platelet-rich Plasma
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Application
5.2.1 Introduction
5.2.2 Spinal Fusion Surgeries
5.2.3 Delayed Union & Nonunion Bone Fractures
5.2.4 Other Applications
5.2.5 Y-o-Y Growth Analysis, By Application
5.2.6 Market Attractiveness Analysis, By Application
5.2.7 Market Share Analysis, By Application
5.3 End user
5.3.1 Introduction
5.3.2 Hospitals and Clinics
5.3.3 Home Care
5.3.4 Academic & Research Institutes
5.3.5 CROs
5.3.6 Y-o-Y Growth Analysis, By End user
5.3.7 Market Attractiveness Analysis, By End user
5.3.8 Market Share Analysis, By End user
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Application
6.1.3.4 By End user
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Application
6.1.4.4 By End user
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Application
6.1.5.4 By End user
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 DJO LLC
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Orthofix International N.V
8.3 Zimmer Biomet Holdings Inc
8.4 Elizur, Bioventus LLC
8.5 Ossatec Benelux BV
8.6 Verve Consulting Inc
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
